Introduction to the main contraindications of budesonide oral suspension (Eohilia)
The main contraindications for budesonide oral suspension (Eohilia) as a topical corticosteroid formulation center on allergic reactions and severe systemic disease. The primary contraindication is patients who are allergic to budesonide or other components of the preparation. Such patients may experience eosinophilia, anaphylaxis or even severe allergic events after use. Overseas clinical literature has repeatedly emphasized that patients with a history of allergy to budesonide should be strictly prohibited from using it to avoid the occurrence of life-threatening adverse events.
In addition, Eohilia should be used with caution in patients with immunocompromised immune systems. Although local absorption of the drug is relatively low, glucocorticoids may still have some suppressive effects on the immune system, especially when used long-term or at high doses. Therefore, clinicians usually assess the patient's immune status and comorbidities before initiating treatment to reduce potential risks.
Use during pregnancy and lactation is also contraindicated or should be used with caution. Existing data are insufficient to fully assess the effects of budesonide on the fetus or infant, so overseas guidelines generally recommend that pregnant women avoid its use and that women of childbearing age should use effective contraceptive measures during treatment. For lactating patients, the benefits of the drug should also be weighed against the potential risks, and alternatives should be selected if necessary.
Other conditions of concern include patients with severe systemic fungal or viral infections. Glucocorticoids have immunosuppressive effects and may aggravate the risk of potential infections, so changes in symptoms should be strictly monitored during use of Eohilia.
In short,Eohilia, as an important therapeutic drug for eosinophilicesophagitis, has significant effects on local anti-inflammation and improving swallowing function. However, contraindications and potential risks must be paid attention to during use. Strictly following the contraindication guidelines and using it under the guidance of a doctor are the basis for ensuring the safety and effectiveness of budesonide oral suspension.
Reference materials:https://www.eohilia.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)